BioTech 365

OCTOBER 8, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Pfizer, Bayer-backed Pyxis ups IPO price as biotech’s public run continues unabated.Pfizer, Bayer-backed Pyxis ups IPO price as biotech’s public run continues unabated badams Fri, 10/08/2021 – … Continue (..)

Research 40

Research 40

BioTech 365

JULY 19, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Adagio seeks IPO to bring COVID-19 antibody to market in 2022.Adagio Adagio seeks IPO to bring COVID-19 antibody to market in 2022 ntaylor Mon, 07/19/2021 – 07:24 from … Continue reading →

Antibody 40

Antibody Marketing Research 40

BioTech 365

OCTOBER 30, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Galecto raise US$85m in Nasdaq IPO. from European Biotechnology – first and foremost in European biotech [link].

Research 40

Research 40

BioTech 365

JUNE 8, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Graphite files for $100M IPO to fund push to cure sickle cell.Graphite files for $100M IPO to fund push to cure sickle cell ntaylor Tue, 06/08/2021 – … Continue reading →

Research 40

Research 40

BioTech 365

MAY 28, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: HCW files for $50M IPO to trial fusion protein in solid tumors.HCW files for $50M IPO to trial fusion protein in solid tumors ntaylor Fri, 05/28/2021 – … Continue reading →

Protein 40

Protein Trials Research 40

BioTech 365

MAY 21, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Merck-partnered Janux seeks $100M IPO on preclinical promise of bispecific pipeline.Merck-partnered Janux seeks $100M IPO on preclinical promise of bispecific pipeline ntaylor Fri, 05/21/2021 – 05:27 from … Continue (..)

Research 40

Research 40

BioTech 365

APRIL 30, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Werewolf Therapeutics howls onto the Nasdaq with $120M IPO.Werewolf Therapeutics howls onto the Nasdaq with $120M IPO aalidrus Fri, 04/30/2021 – 09:25 from FierceBiotech: Biotech [link].

Research 40

Research 40

BioTech 365

JANUARY 26, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Immunocore IPO filing reveals kickback scheme, Immatics row and phishing attacks.Immunocore IPO filing reveals kickback scheme, Immatics row and phishing attacks ntaylor Tue, 01/26/2021 – 08:23 from … Continue reading (..)

Research 40

Research 40

BioTech 365

NOVEMBER 4, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Inhibikase Therapeutics slahes deal size ahead of IPO.Inhibikase Therapeutics slahes deal size ahead of IPO badams Wed, 11/04/2020 – 07:31 from FierceBiotech: Biotech [link].

Research 40

Research 40

BioTech 365

SEPTEMBER 21, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bischofberger’s Kronos files for IPO to run pivotal cancer trial.Bischofberger’s Kronos files for IPO to run pivotal cancer trial ntaylor Mon, 09/21/2020 – 08:03 from FierceBiotech: Biotech … Continue reading (..)

Trials 40

Trials Research 40

BioTech 365

JUNE 25, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Alzheimer’s biotech Acumen prices $125M IPO, targets phase 2 data on amyloid-beta prospect.Alzheimer’s biotech Acumen prices $125M IPO, targets phase 2 data on amyloid-beta prospect ntaylor Fri, … Continue reading (..)

Research 40

Research 40

BioTech 365

MAY 27, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: EFFECTOR Therapeutics bugs out of an IPO, taking the SPAC path with Locust Walk .EFFECTOR

Research 40

Research 40

BioTech 365

APRIL 12, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: COVID player and Pfizer-partnered Valneva eyes $100M Nasdaq IPO.COVID player and Pfizer-partnered Valneva eyes $100M Nasdaq IPO badams Mon, 04/12/2021 – 10:25 from FierceBiotech: Biotech [link].

Research 40

Research 40

BioTech 365

APRIL 2, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: After name change and dropped IPO, IN8bio tries again to boost its cancer pipeline.After name change and dropped IPO, IN8bio tries again to boost its cancer pipeline … Continue reading →

Research 40

Research 40

BioTech 365

SEPTEMBER 20, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO to take cancer drugs into the clinic.Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO to … Continue reading →

Drugs 40

Drugs Research 40

BioTech 365

FEBRUARY 5, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer work.Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer work badams Fri, 02/05/2021 – … Continue reading →

Research 40

Research 40

BioTech 365

DECEMBER 4, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Silverback hits Wall Street with chest-thumping $242M IPO.Silverback hits Wall Street with chest-thumping $242M IPO badams Fri, 12/04/2020 – 08:40 from FierceBiotech: Biotech [link].

Research 40

Research 40

BioTech 365

SEPTEMBER 2, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Compass plans IPO to take ‘magic mushroom’ drug to phase 3.Compass

Drugs 40

Drugs Research 40

BioTech 365

MARCH 26, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gyroscope bags $148M for AMD gene therapy trials, mulls IPO.Gyroscope bags $148M for AMD gene therapy trials, mulls IPO ntaylor Fri, 03/26/2021 – 08:46 from FierceBiotech: Biotech … Continue reading →

Gene Therapy 40

Gene Therapy Gene Trials Research 40

BioTech 365

JANUARY 20, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Adagene plans $125M IPO to go after cancer niches targeted by BMS and Pfizer.Adagene plans $125M IPO to go after cancer niches targeted by BMS and Pfizer … Continue reading →

Research 40

Research 40

BioTech 365

SEPTEMBER 22, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: IPO, check: Now, ADC Therapeutics files for lonca approval.IPO, check: Now, ADC Therapeutics files for lonca approval badams Tue, 09/22/2020 – 03:37 from FierceBiotech: Biotech [link].

Research 40

Research 40

BioTech 365

OCTOBER 21, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Ventyx nabs a $152M upsized IPO to challenge BMS’ Zeposia—and a backer with intimate knowledge of its rival.Ventyx nabs a $152M upsized IPO to challenge BMS’ Zeposia—and … Continue reading →

Research 40

Research 40

BioTech 365

AUGUST 17, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Juno joint venture seeks IPO haul to bring CAR-Ts to China.Juno joint venture seeks IPO haul to bring CAR-Ts to China ntaylor Mon, 08/17/2020 – 08:32 from … Continue reading →

Research 40

Research 40

BioTech 365

MARCH 26, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: British T-cell cancer biotech Achilles Therapeutics guns for $176M IPO.British T-cell cancer biotech Achilles Therapeutics guns for $176M IPO badams Fri, 03/26/2021 – 07:01 from FierceBiotech: Biotech … Continue reading (..)

Research 40

Research 40

BioTech 365

JULY 2, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Eschewing an IPO (for now), Sirnaomics nabs a rare series E worth $105M for next-gen RNA work.Eschewing an IPO (for now), Sirnaomics nabs a rare series E … Continue reading →

RNA 40

RNA Research 40

BioTech 365

JANUARY 15, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Landos Biopharma guns for a $100 million IPO to boost AI autoimmune R&D work.Landos Biopharma guns for a $100 million IPO to boost AI autoimmune R&D work … Continue reading →

Research 40

Research 40

BioTech 365

APRIL 13, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Recursion, targeting cancer, rare disease midstage tests, sets terms for $306M IPO.Recursion, targeting cancer, rare disease midstage tests, sets terms for $306M IPO badams Tue, 04/13/2021 – … Continue reading → (..)

Research 40

Research 40

BioTech 365

NOVEMBER 9, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: RemeGen grabs one of the world’s largest ever biotech IPOs.RemeGen grabs one of the world’s largest ever biotech IPOs badams Mon, 11/09/2020 – 05:17 from FierceBiotech: Biotech … Continue reading → (..)

Research 40

Research 40

BioTech 365

NOVEMBER 8, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gyroscope spins the wheel again as it taps Sanofi for $60M months after ditching IPO attempt.Gyroscope spins the wheel again as it taps Sanofi for $60M months … Continue reading →

Research 40

Research 40

BioTech 365

DECEMBER 7, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation.AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with … Continue reading →

Antibody 40

Antibody Research 40

BioTech 365

DECEMBER 22, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: In spite of COVID-19—and partly because of it—biotech IPOs have a record year.In spite of COVID-19—and partly because of it—biotech IPOs have a record year badams Thu, … Continue reading →

Research 40

Research 40

BioTech 365

AUGUST 28, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Athira, armed with data on 11 patients, plans $100M IPO to fund pivotal Alzheimer’s trial.Athira, armed with data on 11 patients, plans $100M IPO to fund pivotal … Continue reading →

Trials 40

Trials Research 40

BioTech 365

OCTOBER 5, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Foghorn blows its klaxon, gunning for a $100M IPO hot on the heels of its Merck deal.Foghorn blows its klaxon, gunning for a $100M IPO hot on … Continue reading →

Research 40

Research 40

BioTech 365

APRIL 12, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Vaccitech, the company that developed the AstraZeneca COVID-19 shot, files for a Nasdaq IPO.Vaccitech, the company that developed the AstraZeneca COVID-19 shot, files for a Nasdaq IPO … Continue reading →

Development 40

Development Research 40

BioTech 365

JANUARY 21, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: After bagging Yescarta exec as CMO, T-cell biotech NexImmune files for $86M IPO.After bagging Yescarta exec as CMO, T-cell biotech NexImmune files for $86M IPO badams Thu, … Continue reading →

Research 40

Research 40

BioTech 365

SEPTEMBER 11, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: First order of business for brand new C4 Therapeutics chief Hirsch: A $100M IPO.First order of business for brand new C4 Therapeutics chief Hirsch: A $100M IPO … Continue reading →

Branding 40

Branding Research 40

BioTech 365

JANUARY 14, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Secretive Sana, still a year away from the clinic, files for an IPO after a mammoth raise.Secretive Sana, still a year away from the clinic, files for … Continue reading →

Research 40

Research 40